Humanigen Inc (HGENQ)
0.0002
USD |
OTCM |
May 16, 16:00
Humanigen Free Cash Flow (Quarterly): -7.059M for March 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | -7.059M |
| December 31, 2022 | -14.57M |
| September 30, 2022 | -17.31M |
| June 30, 2022 | -25.38M |
| March 31, 2022 | -19.44M |
| December 31, 2021 | -32.26M |
| September 30, 2021 | -48.00M |
| June 30, 2021 | -67.96M |
| March 31, 2021 | -35.82M |
| December 31, 2020 | -23.70M |
| September 30, 2020 | -23.56M |
| June 30, 2020 | -22.01M |
| March 31, 2020 | -0.607M |
| December 31, 2019 | -0.549M |
| September 30, 2019 | -1.179M |
| June 30, 2019 | -1.589M |
| March 31, 2019 | -0.684M |
| December 31, 2018 | -1.224M |
| September 30, 2018 | -1.254M |
| June 30, 2018 | -1.903M |
| March 31, 2018 | -1.828M |
| December 31, 2017 | -1.938M |
| September 30, 2017 | -4.008M |
| Date | Value |
|---|---|
| June 30, 2017 | -3.938M |
| March 31, 2017 | -4.365M |
| December 31, 2016 | -3.013M |
| September 30, 2016 | -8.988M |
| June 30, 2016 | -6.963M |
| March 31, 2016 | -1.997M |
| December 31, 2015 | -7.994M |
| September 30, 2015 | -6.225M |
| June 30, 2015 | -5.857M |
| March 31, 2015 | -9.123M |
| December 31, 2014 | -6.993M |
| September 30, 2014 | -8.424M |
| June 30, 2014 | -9.637M |
| March 31, 2014 | -11.33M |
| December 31, 2013 | -10.10M |
| September 30, 2013 | -8.631M |
| June 30, 2013 | -12.62M |
| March 31, 2013 | -7.806M |
| December 31, 2012 | -8.558M |
| September 30, 2012 | -6.612M |
| June 30, 2012 | -5.29M |
| March 31, 2012 | -3.446M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-67.96M
Minimum
Jun 2021
-0.549M
Maximum
Dec 2019
-21.31M
Average
-20.72M
Median
Free Cash Flow (Quarterly) Benchmarks
| Item 9 Labs Corp | 0.0873M |
| Cantabio Pharmaceuticals Inc | -- |
| Affymax Inc | -- |
| Scopus BioPharma Inc | -1.009M |
| Statera BioPharma Inc | -- |